MiRus®, the medical device company developing innovative solutions for spinal, orthopaedic, and structural heart conditions, has landed a significant $1.5B investment.
The privately held firm, launched in 2016, received capital from Boston Scientific. MiRus provides a range of pre-operative, intra-operative, and post-operative solutions, utilizing proprietary alloys, innovative implant designs, and remote physiologic monitoring platforms to improve patient outcomes.















